Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume 19, Issue 9, Pages 608-614
Publisher
Wiley
Online
2012-01-28
DOI
10.1111/j.1365-2893.2011.01580.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C
- (2011) Eric Trépo et al. HEPATOLOGY
- The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C
- (2011) Nicole T. do O et al. HEPATOLOGY
- A polymorphism that delays fibrosis in hepatitis C promotes alternative splicing of AZIN1, reducing fibrogenesis
- (2011) Andrew J. Paris et al. HEPATOLOGY
- Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection
- (2011) Francesco Marabita et al. HEPATOLOGY
- Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype
- (2011) Edmondo Falleti et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus–Hepatitis C Virus–Coinfected Patients Receiving Antiretroviral Therapy
- (2011) Pablo Barreiro et al. JOURNAL OF INFECTIOUS DISEASES
- Interferon receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection
- (2010) B. Nalpas et al. GUT
- Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
- (2010) Luca Valenti et al. HEPATOLOGY
- Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression
- (2010) Masashi Sakaki et al. HEPATOLOGY RESEARCH
- Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients
- (2010) Hiromi Abe et al. JOURNAL OF HEPATOLOGY
- Functional variants of COX-2 and risk of tobacco-related oral squamous cell carcinoma in high-risk Asian Indians
- (2010) Manasi Mittal et al. ORAL ONCOLOGY
- Polymorphism in COX-2 modifies the inverse association between Helicobacter pyloriseropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
- (2009) Huang-Ming Hu et al. BMC GASTROENTEROLOGY
- Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication
- (2009) Chang-Zheng Li et al. LIVER INTERNATIONAL
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the −1195G > A promoter polymorphism with mild asthma
- (2008) J. Shi et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence
- (2008) Kazumasa Hiroishi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now